Net profit of Ajanta Pharma rose 17.56% to Rs 273.77 crore in the quarter ended December 2025 as against Rs 232.88 crore during the previous quarter ended December 2024. Sales rose 19.95% to Rs 1374.84 crore in the quarter ended December 2025 as against Rs 1146.13 crore during the previous quarter ended December 2024. ParticularsQuarter EndedDec. 2025Dec. 2024% Var. Sales1374.841146.13 20 OPM %27.8027.99 - PBDT402.11343.36 17 PBT358.60307.39 17 NP273.77232.88 18 Powered by Capital Market - Live News

Ajanta Pharma will hold a meeting of the Board of Directors of the Company on 30 January 2026.Powered by Capital Market - Live News

Ajanta Pharma announced that the Board of Directors of the Company at its meeting held on 3 November 2025, inter alia, have recommended the interim dividend of Rs 28 per equity Share (i.e. 1400%) , subject to the approval of the shareholders.Powered by Capital Market - Live News

Net profit of Ajanta Pharma rose 20.19% to Rs 260.19 crore in the quarter ended September 2025 as against Rs 216.48 crore during the previous quarter ended September 2024. Sales rose 14.08% to Rs 1353.73 crore in the quarter ended September 2025 as against Rs 1186.64 crore during the previous quarter ended September 2024. ParticularsQuarter EndedSep. 2025Sep. 2024% Var. Sales1353.731186.64 14 OPM %24.2226.22 - PBDT383.78324.63 18 PBT340.81290.24 17 NP260.19216.48 20 Powered by Capital Market - Live News

Ajanta Pharma will hold a meeting of the Board of Directors of the Company on 3 November 2025.Powered by Capital Market - Live News